Many Fox Chase Cancer Center (FCCC) studies, including those in cancer control and prevention, translational research, human genetics, behavioral medicine and some animal trials employ a variety of designs that are substantially more complex than typical cancer clinical trials. These investigations require development of study-specific information systems for project management, and the collection, validation, storage, and retrieval of data. The Population Studies Facility (PSF) facilitates research conducted by FCCC peer-reviewed, funded investigators by providing access to a team of information systems professionals with experience in state-of-the-art software engineering applied to cancer research. The PSF functions include development of;databases for the storage and manipulation of large quantities of questionnaire, clinical, molecular and specimen data;electronic data entry and retrieval systems;report generation software;consistency and quality control systems;and systems that provide integration and controlled exchange of data from diverse sources. For example, the system developed by the PSF for the """"""""Breast Cancer Family Registry"""""""" study provides for the entry, coordination and retrieval of longitudinal information, specimen inventory, genetic testing, and complex pedigree data. The PSF also provides systems that facilitate the peer-reviewed, funded investigator support activities of many CCSG-supported cores. The PSF has developed information systems that maintain data on over 180,000 subjects. Of these, more than 60,000 were enrolled in FCCC studies within the US;the remainder participated in several international cohort studies. The PSF provided services to 54 peer-reviewed, funded investigators in all five Programs and 129 projects over the last five years. These represent 35% and 6 1% increases in the number of supported investigators and projects, respectively, over the previous funding cycle. Improved application development efficiency provided by the PSF's creation of the Population Research Application Generation Environment (PRESAGE) toolset and the use of open source solutions has allowed the PSF to accommodate the increase in demand for informatics services with only a 9% increase in staffing. The PSF made contributions to 100 manuscripts and PSF personnel have appeared as co-authors on 47 publications over the current funding period. It has a user charge back system that, combined with other direct grant funding, recoups 74% of its operating cost. In 2009, 66.2% of its use was directly for peer-reviewed, funded investigators. This Facility was rated """"""""Outstanding"""""""" during the last review.

Public Health Relevance

The Population Studies Facility (PSF) provides state of the art software engineering applied to cancer research which include: database storage, manipulation of large quantities of questionnaires, clinical and other data entry and retrieval systems. The PSF is critical in maintaining data on over 180,000 subjects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-49
Application #
8379819
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
49
Fiscal Year
2012
Total Cost
$159,339
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Sementino, Eleonora; Menges, Craig W; Kadariya, Yuwaraj et al. (2018) Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. J Cell Physiol 233:8952-8961
Gupta, Sapna; Kelow, Simon; Wang, Liqun et al. (2018) Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine ?-synthase (CBS) reveal effects on CBS activity but not stability. J Biol Chem 293:13921-13931
Peng, Hongzhuang; Prokop, Jeremy; Karar, Jayashree et al. (2018) Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res 78:1200-1213
Araiza-Olivera, Daniela; Chernoff, Jonathan (2018) Hras helps hippo heterodimerize to evade tumor suppression. Small GTPases 9:327-331
Shaikh, Talha; Handorf, Elizabeth A; Meyer, Joshua E et al. (2018) Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol 4:e173580
Reese, Jennifer Barsky; Smith, Katherine Clegg; Handorf, Elizabeth et al. (2018) A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol :1-22
Auerbach, M V; Heckman, C J; Darlow, S (2018) To protect or not to protect: examining reasons for sun protection among young women at risk for skin cancer. J Behav Med 41:528-536
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886

Showing the most recent 10 out of 1280 publications